CVR 41600039Public limited company (A/S)Computerprogrammering (621000)Secondary industries: Aktiviteter inden for hospitalsvæsen (861000)København KFounded 13 Aug 2020
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Medable A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2024
Gross profit
30.7M
DKK, annual report 2023
-30% on 2022
Result
-6.2M
DKK, annual report 2023
Equity
102.9M
DKK, annual report 2023
Medable Inc.100% of capital and votes, until 11 Jun 2025
Marc Steven Ginskyuntil 3 Apr 2024
No current owner is registered.
CVR 56759514100% of capital and votesnotified 31 Jan 202213 Aug 2020 to 31 Jan 2022
100% of capital and votes31 Jan 2022 to 11 Jun 2025
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
May 2024, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 38 | 40 | 40 | 41 | 40 | 41 | 40 | 39 | 35 | 31 | 31 | 33 | 32 | 33 | 32 | 32 | 30 | 30 | 31 | 32 | 32 | 33 | 32 | 31 | 32 | 33 | 34 | 34 | 28 | 27 | 27 | 22 | 21 | 19 | 16 | 14 | 13 | 13 | 13 | 9 | 10 | 1 | 1 | 1 | 1 |
| FTE | 36 | 38 | 38 | 38 | 38 | 39 | 37 | 37 | 32 | 28 | 29 | 29 | 30 | 31 | 31 | 30 | 28 | 29 | 29 | 31 | 31 | 31 | 31 | 30 | 31 | 32 | 33 | 33 | 27 | 27 | 26 | 22 | 21 | 19 | 16 | 14 | 13 | 13 | 12 | 9 | 10 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest May 2024, published 28 Aug 2024.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2023, DKK: Gross profit 30.7M, Operating profit -6.4M, Result for the year -6.2M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2023, DKK: Total assets 104M, Equity 102.9M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 |
|---|---|---|---|
| Gross profit | -4,710 | 43,853 | 30,676 |
| Operating profit | -105,640 | +2,500 | -6,416 |
| Result for the year | -99,670 | +4,833 | -6,219 |
| Equity | 42,079 | 74,097 | 102,879 |
| Total assets | 48,005 | 74,538 | 104,015 |
| Employees (average) | 35 | 31 | 18 |
| Credit metrics (Dandex calculations) | |||
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | n.m.note 2 | -30% |
| EBITDA | -13,653 | 7,004 | 3,544 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | -11.4% | -41.9% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||
| Capex (investeringer i anlægsaktiver) | Not reportednote 3 | 0note 4 | 0note 4 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||
Not every period is a full year: 2021 covers 17 months (13 Aug 2020 to 31 Dec 2021). Changes against it compare periods of different length.
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Medable A/S:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseContribution in kindPaid in 141,349,380 | None | 141,349,380 | None | 1,000,000 | |
| FoundingCashPaid in 400,000 | None | 400,000 | None | 400,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
15 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Binavne:
Omhu A/S I LIKVIDATION
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Claudia Elisabeth Sønderskov Mathiasen, den 11.06.2025.
Revision:
Fratrådte:
Forvis Mazars Statsautoriseret Revisionspartnerselskab, den 11.06.2025.
Likvidation vedtaget 03.04.2024
Ny adresse: c/o Winsløw Advokatfirma, Gammel Strand 34, 1202 København K
Likvidatorer:
Tiltrådte:
Claudia Elisabeth Sønderskov Mathiasen, 1202 København K, den 03.04.2024.
Bestyrelse:
Fratrådte:
Amar Deepak Jani, den 03.04.2024, Marc Ginsky, den 03.04.2024, Michelle Rae Longmire, (formand), den 03.04.2024.
Direktion:
Fratrådte:
Marc Steven Ginsky, (adm. dir), den 03.04.2024.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Direktion:
Fratrådte:
Jawahar Malhotra, (adm. dir), den 03.08.2023.
Tiltrådte:
Marc Steven Ginsky, (adm. dir), den 03.08.2023.
Revision:
Tiltrådte:
CVR-NR. 31061741 MAZARS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Midtermolen 1, 2. tv, 2100 København Ø, den 08.05.2023.
Revision:
Fratrådte:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 02.05.2023.
Ny adresse: Havnegade 25, 1058 København K
Direktion:
Fratrådte:
Christian Mulvad Sejersen, (adm. dir), den 29.06.2022.
Tiltrådte:
Jawahar Malhotra, (adm. dir), den 30.06.2022.
Vedtægter ændret: 02.06.2022
Nyt navn: Medable A/S
Nyt binavn: Omhu A/S
Bestyrelse:
Fratrådte:
Perry Christian Robinson, den 02.06.2022.
Bestyrelse:
Fratrådte:
John Krayacich, den 31.01.2022.
Vedtægter ændret: 31.01.2022
Bestyrelse:
Fratrådte:
Anne Cathrine Fleischer, den 31.01.2022, Anders Kronborg, (formand), den 31.01.2022.
Tiltrådte:
Michelle Rae Longmire, (formand), den 31.01.2022, Perry Christian Robinson, den 31.01.2022.
Vedtægter ændret: 01.09.2020
Kapitalforhøjelsen er besluttet den 01.09.2020.
kr. 600.000,00, indbetalt i værdier, kurs 23.558,23.
Kapitalen udgør herefter kr. 1.000.000,00.
Stiftelsesdato: 13.08.2020.
Virkningsdato: 13.08.2020.
Seneste vedtægtsdato: 13.08.2020.
Kapital:
kr. 400.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 400.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 56759514 LEO PHARMA A/S, Industriparken 55, 2750 Ballerup, den 13.08.2020.
Bestyrelse:
Anders Kronborg, (formand), den 13.08.2020, Anne Cathrine Fleischer, den 13.08.2020, John Krayacich, den 13.08.2020.
Direktion:
Christian Mulvad Sejersen, (adm. dir), den 13.08.2020.
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af bestyrelsesformanden i forening med en direktør.
Revision:
CVR-NR. 33963556 DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Weidekampsgade 6, 2300 København S, den 13.08.2020.
Første regnskabsår:
13.08.2020 - 31.12.2021.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er drive virksomhed inden for healthcare samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
P-number 1026164717Gammel Strand 34, 1202 København K